| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | C Gotti | |
| F Clementi | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| P304 | page(s) | 363-96 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Progress in Neurobiology | Q15716615 |
| P1476 | title | Neuronal nicotinic receptors: from structure to pathology | |
| P478 | volume | 74 |
| Q91896114 | A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System |
| Q48370390 | A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery |
| Q33833362 | A Novel Lid-Covering Peptide Inhibitor of Nicotinic Acetylcholine Receptors Derived from αD-Conotoxin GeXXA. |
| Q37227203 | A biosocial developmental model of borderline personality: Elaborating and extending Linehan's theory |
| Q35751886 | A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk |
| Q27681218 | A novel 4/7-conotoxin LvIA from Conus lividus that selectively blocks 3 2 vs. 6/ 3 2 3 nicotinic acetylcholine receptors |
| Q24632726 | A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD |
| Q33620592 | A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia |
| Q46093396 | ADHD diagnosis may influence the association between polymorphisms in nicotinic acetylcholine receptor genes and tobacco smoking |
| Q35111465 | AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation |
| Q34577233 | ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors |
| Q57040567 | Acetylcholine signaling system in progression of lung cancers |
| Q37725116 | Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. |
| Q38502087 | Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia |
| Q36807622 | Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist |
| Q30587128 | Activation of α2A-containing nicotinic acetylcholine receptors mediates nicotine-induced motor output in embryonic zebrafish |
| Q37707730 | Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors |
| Q85244116 | Activation of α7 nicotinic acetylcholine receptors ameliorates indomethacin-induced small intestinal ulceration in mice |
| Q38264151 | Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity |
| Q89952539 | Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators |
| Q46875243 | Agonist- and competitive antagonist-induced movement of loop 5 on the alpha subunit of the neuronal alpha4beta4 nicotinic acetylcholine receptor |
| Q33240001 | Airway-related vagal preganglionic neurons express multiple nicotinic acetylcholine receptor subunits |
| Q36764756 | Alcohol's actions on neuronal nicotinic acetylcholine receptors. |
| Q35182101 | Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors |
| Q34078196 | Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells |
| Q53397808 | Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1. |
| Q37800819 | Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases |
| Q42951050 | Ameliorating effects of tropisetron on dopaminergic disruption of prepulse inhibition via the α7 nicotinic acetylcholine receptor in Wistar rats |
| Q34978892 | An allosteric modulator of alpha7 nicotinic receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), causes conformational changes in the extracellular ligand binding domain similar to those caused by acetylcholine |
| Q35990855 | An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modification |
| Q83835025 | Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743 |
| Q30432768 | Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans |
| Q35473808 | Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women |
| Q41636544 | Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence |
| Q27650600 | Atomic interactions of neonicotinoid agonists with AChBP: Molecular recognition of the distinctive electronegative pharmacophore |
| Q34257782 | Atomistic insights into human Cys-loop receptors by solution NMR. |
| Q89404653 | Augmenting the antinociceptive effects of nicotinic acetylcholine receptor activity through lynx1 modulation |
| Q57401033 | Au–Mesoporous silica nanoparticles gated with disulfide-linked oligo(ethylene glycol) chains for tunable cargo delivery mediated by an integrated enzymatic control unit |
| Q42121818 | B6eGFPChAT mice overexpressing the vesicular acetylcholine transporter exhibit spontaneous hypoactivity and enhanced exploration in novel environments |
| Q33736687 | Bioactive marine drugs and marine biomaterials for brain diseases |
| Q41764058 | Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation |
| Q46345641 | Brain activation by short-term nicotine exposure in anesthetized wild-type and beta2-nicotinic receptors knockout mice: a BOLD fMRI study. |
| Q38598715 | CHRFAM7A: a human-specific α7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS |
| Q40413207 | Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells |
| Q33273397 | Central nicotinic receptors: structure, function, ligands, and therapeutic potential. |
| Q50647899 | Chaperone protein 14-3-3 and protein kinase A increase the relative abundance of low agonist sensitivity human alpha 4 beta 2 nicotinic acetylcholine receptors in Xenopus oocytes. |
| Q27680549 | Characterization of a Novel α-Conotoxin TxID from Conus textile That Potently Blocks Rat α3β4 Nicotinic Acetylcholine Receptors |
| Q24630903 | Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression |
| Q35033211 | Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease? |
| Q36756379 | Cholinergic circuits and signaling in the pathophysiology of schizophrenia |
| Q36042479 | Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions |
| Q26991451 | Cholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activity |
| Q42556634 | Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation |
| Q36596497 | Cholinergic regulation of epithelial ion transport in the mammalian intestine |
| Q37239371 | Chronic nicotine exposure stimulates biliary growth and fibrosis in normal rats |
| Q46450404 | Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. |
| Q34712735 | Cloning and spatiotemporal expression of zebrafish neuronal nicotinic acetylcholine receptor alpha 6 and alpha 4 subunit RNAs |
| Q37034247 | Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning |
| Q37376724 | Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics |
| Q92880489 | Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation |
| Q62887568 | Complex Control of Striatal Neurotransmission by Nicotinic Acetylcholine Receptors via Excitatory Inputs onto Medium Spiny Neurons |
| Q26783037 | Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management? |
| Q33736765 | Conotoxins targeting nicotinic acetylcholine receptors: an overview |
| Q40072727 | Construction of SH-EP1-alpha4beta2-hAPP695 cell line and effects of nicotinic agonists on beta-amyloid in the cells |
| Q37372238 | Coupling of ionic events to protein kinase signaling cascades upon activation of alpha7 nicotinic receptor: cooperative regulation of alpha2-integrin expression and Rho kinase activity |
| Q37168375 | Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed. |
| Q30503572 | Critical role of peripheral actions of intravenous nicotine in mediating its central effects. |
| Q35879010 | Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons |
| Q36044791 | Crystallization scale purification of α7 nicotinic acetylcholine receptor from mammalian cells using a BacMam expression system |
| Q44225611 | Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice |
| Q92636868 | DSPE-PEG Modification of α-Conotoxin TxID |
| Q45985006 | Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease. |
| Q35209559 | Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD |
| Q41916908 | Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors |
| Q35745950 | Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor. |
| Q34167942 | Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors |
| Q33668630 | Determinants of alpha-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor beta subunit |
| Q38558845 | Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography |
| Q37058925 | Differential Effects of Quercetin and Quercetin Glycosides on Human α7 Nicotinic Acetylcholine Receptor-Mediated Ion Currents |
| Q38309431 | Differential brain transcriptome of beta4 nAChR subunit-deficient mice: is it the effect of the null mutation or the background strain? |
| Q37535489 | Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions |
| Q36184313 | Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). |
| Q36358074 | Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes |
| Q42652289 | Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. |
| Q26749755 | Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT |
| Q36511661 | Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment. |
| Q36421837 | Dynamic structural investigations on the torpedo nicotinic acetylcholine receptor by time-resolved photoaffinity labeling |
| Q90624729 | Dynamics and Interactions of GPI-Linked lynx1 Protein with/without Nicotinic Acetylcholine Receptor in Membrane Bilayers |
| Q34602337 | Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers |
| Q37351302 | Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats |
| Q36850568 | Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration |
| Q37642452 | Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration |
| Q37231098 | Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies |
| Q46560369 | Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism |
| Q48689535 | Effects of quercetin on α9α10 nicotinic acetylcholine receptor-mediated ion currents |
| Q37121061 | Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats |
| Q43136266 | Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats |
| Q38732866 | Effects of varenicline on alcohol cue reactivity in heavy drinkers |
| Q92187690 | Electroacupuncture Pretreatment Alleviates Cerebral Ischemic Injury Through α7 Nicotinic Acetylcholine Receptor-Mediated Phenotypic Conversion of Microglia |
| Q45778608 | Electron ionization mass spectral study of oxo- and thio derivatives of minor tobacco alkaloids |
| Q36658255 | Emerging concepts: novel integration of in vivo approaches to localize the function of nicotinic receptors |
| Q46808737 | Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes |
| Q97595720 | Endogenous neurotoxin-like protein Ly6H inhibits alpha7 nicotinic acetylcholine receptor currents at the plasma membrane |
| Q42614063 | Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit. |
| Q35892732 | Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats: modulation by serotonin-3 and nicotinic cholinergic receptors |
| Q53490437 | Enzyme-Controlled Nanodevice for Acetylcholine-Triggered Cargo Delivery Based on Janus Au-Mesoporous Silica Nanoparticles. |
| Q48210848 | Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. |
| Q42864783 | Evidence of alpha 7 nicotinic acetylcholine receptor expression in retinal pigment epithelial cells. |
| Q33866877 | Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases |
| Q35651396 | Expression of neuronal nicotinic acetylcholine receptors in rat vagal pulmonary sensory neurons. |
| Q31005986 | Extracellular domain nicotinic acetylcholine receptors formed by alpha4 and beta2 subunits |
| Q30472645 | FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERY |
| Q36757456 | Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo |
| Q36310658 | Flexible synthesis of poison-frog alkaloids of the 5,8-disubstituted indolizidine-class. II: Synthesis of (-)-209B, (-)-231C, (-)-233D, (-)-235B", (-)-221I, and an epimer of 193E and pharmacological effects at neuronal nicotinic acetylcholine recept |
| Q35104827 | From smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors |
| Q46146798 | Functional alpha 7-containing nicotinic receptors of NG2-expressing cells in the hippocampus. |
| Q42456963 | Functional expression and axonal transport of α7 nAChRs by peptidergic nociceptors of rat dorsal root ganglion |
| Q46365543 | Functional expression of nicotinic acetylcholine receptors in rat neocortical layer 5 pyramidal cells |
| Q38492852 | Functionally significant nicotine acetylcholine receptor subunit α5 promoter haplotypes are associated with susceptibility to lung cancer in Chinese |
| Q47104016 | G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides |
| Q24298343 | Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence |
| Q35237992 | Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence |
| Q46434067 | Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease |
| Q30491854 | Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction |
| Q36581848 | Glucose attenuates impairments in memory and CREB activation produced by an α4β2 but not an α7 nicotinic receptor antagonist |
| Q36560437 | Guidelines on nicotine dose selection for in vivo research. |
| Q99417452 | Hair cell α9α10 nicotinic acetylcholine receptor functional expression regulated by ligand binding and deafness gene products |
| Q44052483 | Human biodistribution and dosimetry of [18F]nifene, an α4β2* nicotinic acetylcholine receptor PET tracer. |
| Q38810282 | Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research |
| Q42221019 | ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling |
| Q33833386 | Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor |
| Q35738694 | Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity |
| Q34409044 | Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain |
| Q37003060 | Identifying the lipid-protein interface of the alpha4beta2 neuronal nicotinic acetylcholine receptor: hydrophobic photolabeling studies with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine. |
| Q38266880 | Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors |
| Q48094212 | Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [18F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions. |
| Q46849785 | Imidacloprid induces neurobehavioral deficits and increases expression of glial fibrillary acidic protein in the motor cortex and hippocampus in offspring rats following in utero exposure |
| Q39342494 | Immunomodulatory effects of nicotine on interleukin 1β activated human astrocytes and the role of cyclooxygenase 2 in the underlying mechanism. |
| Q42636687 | In vivo imaging of presynaptic terminals and postsynaptic sites in the mouse submandibular ganglion |
| Q24678710 | Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear |
| Q39434028 | Influence of cardiac nerve status on cardiovascular regulation and cardioprotection |
| Q39605620 | Influence of disulfide connectivity on structure and bioactivity of α-conotoxin TxIA. |
| Q48428675 | Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex |
| Q35270019 | Inhibitory Effects of Quercetin on Muscle-type of Nicotinic Acetylcholine Receptor-Mediated Ion Currents Expressed in Xenopus Oocytes |
| Q26774441 | Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective |
| Q40111690 | Insights into nicotinic receptor signaling in nicotine addiction: Implications for prevention and treatment. |
| Q92817198 | Interactions of Glutamatergic Neurotransmission and Brain-Derived Neurotrophic Factor in the Regulation of Behaviors after Nicotine Administration |
| Q42220349 | Interactive models of communication at the nanoscale using nanoparticles that talk to one another. |
| Q33471421 | Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers |
| Q42565570 | Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity |
| Q44895743 | Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: a computational and experimental study using epibatidine-related molecular probes |
| Q53742885 | Involvement of N-cholinergic synapses in regulating RNA metabolism in sympathetic neurons and satellite gliocytes. |
| Q37629259 | Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications |
| Q37855929 | Ion channel blockers for the treatment of neuropathic pain |
| Q92210130 | Isomerization of Asp7 in Beta-Amyloid Enhances Inhibition of the α7 Nicotinic Receptor and Promotes Neurotoxicity |
| Q39373447 | Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins |
| Q82345207 | Lack of dystrophin functionally affects α3β2/β4-nicotinic acethylcholine receptors in sympathetic neurons of dystrophic mdx mice |
| Q44986817 | Lactate dehydrogenase isoenzymes in sympathetic neurons and satellite gliocytes in normal conditions and in blockade of nicotinic cholinoreceptors |
| Q33608651 | Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures |
| Q55032134 | Liposomes and lipid disks traverse the BBB and BBTB as intact forms as revealed by two-step Förster resonance energy transfer imaging. |
| Q34374778 | Localization of acetylcholine-related molecules in the retina: implication of the communication from photoreceptor to retinal pigment epithelium |
| Q40354072 | Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells |
| Q24647069 | Mammalian nicotinic acetylcholine receptors: from structure to function |
| Q34565565 | Management of methamphetamine abuse and dependence |
| Q28686906 | Marine Toxins Targeting Ion Channels |
| Q91727941 | Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans |
| Q34363819 | Measuring α4β2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate |
| Q58795483 | Mechanisms Underlying the Strong Inhibition of Muscle-Type Nicotinic Receptors by Tetracaine |
| Q52147631 | Mechanisms of Nicotinic Modulation of Glutamatergic Neuroplasticity in Humans. |
| Q22252966 | Memantine for dementia in people with Down syndrome |
| Q52305450 | Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor. |
| Q24564986 | Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain |
| Q46272595 | Molecular Engineering of Conus Peptides as Therapeutic Leads |
| Q24673308 | Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors |
| Q43038942 | Molecular medicine: entry granted |
| Q90603824 | More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder |
| Q36225080 | More than just a barrier: urothelium as a drug target for urinary bladder pain |
| Q48272239 | Multiple inhibitory actions of lidocaine on Torpedo nicotinic acetylcholine receptors transplanted to Xenopus oocytes |
| Q30459624 | Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia |
| Q36579166 | Muscle-Type Nicotinic Receptor Blockade by Diethylamine, the Hydrophilic Moiety of Lidocaine. |
| Q64250595 | Mutagenesis of α-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors |
| Q39627579 | Mutant human β4 subunit identified in amyotrophic lateral sclerosis patients impairs nicotinic receptor function |
| Q37196810 | Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons |
| Q50123276 | Neuronal and extraneuronal nicotinic acetylcholine receptors |
| Q38181945 | Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence |
| Q37473457 | Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q24614080 | Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition |
| Q46679051 | Neurosteroids in nicotine and morphine dependence |
| Q37783442 | New Insights into the Regulation of Ion Channels by Integrins |
| Q90190112 | Nicotine Gateway Effects on Adolescent Substance Use |
| Q37059455 | Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia |
| Q28082026 | Nicotine and the adolescent brain |
| Q34803242 | Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways |
| Q34849133 | Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines |
| Q34597500 | Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin |
| Q36640128 | Nicotine related brain activity: the influence of smoking history and blood nicotine levels, an exploratory study |
| Q46172398 | Nicotine suppression of gustatory responses of neurons in the nucleus of the solitary tract |
| Q79366421 | Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts |
| Q48582296 | Nicotine-induced enhancement of Pavlovian alcohol-seeking behavior in rats |
| Q94059614 | Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions |
| Q42789671 | Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease. |
| Q46656409 | Nicotinic acetylcholine receptor subtypes involved in facilitation of GABAergic inhibition in mouse superficial superior colliculus |
| Q37346931 | Nicotinic acetylcholine receptor subunits in rhesus monkey retina |
| Q37461914 | Nicotinic acetylcholine receptor α7 and β4 subunits contribute nicotine-induced apoptosis in periodontal ligament stem cells |
| Q53602844 | Nicotinic acetylcholine receptors (nAChR) are increased in the pre-eclamptic placenta. |
| Q37651602 | Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature |
| Q37629127 | Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex. |
| Q38189979 | Nicotinic acetylcholine receptors in human genetic disease |
| Q51977924 | Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. |
| Q48133939 | Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers |
| Q48618313 | Nicotinic cholinergic and dopaminergic receptor mRNA expression in male and female rats with high or low preference for nicotine. |
| Q48929970 | Nicotinic modulation of Ca2+ oscillations in rat cortical neurons in vitro |
| Q30450602 | Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor |
| Q48449811 | Nicotinic modulation of network and synaptic transmission in the immature hippocampus investigated with genetically modified mice |
| Q30993631 | Nicotinic modulation of neuronal networks: from receptors to cognition |
| Q37533310 | Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits |
| Q46523776 | Nicotinic receptor activation contrasts pathophysiological bursting and neurodegeneration evoked by glutamate uptake block on rat hypoglossal motoneurons. |
| Q36564840 | Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms |
| Q37518024 | Nicotinic receptor-based therapeutics and candidates for smoking cessation |
| Q36882136 | Nicotinic receptors as CNS targets for Parkinson's disease |
| Q36828916 | Nicotinic receptors in neurodegeneration |
| Q35229057 | Non-neuronal acetylcholine as an endogenous regulator of proliferation and differentiation of Lgr5-positive stem cells in mice |
| Q37129328 | Nonsynaptic chemical transmission through nicotinic acetylcholine receptors |
| Q37453604 | Novel Conopeptides of Largely Unexplored Indo Pacific Conus sp. |
| Q94568897 | On-resin strategy to label α-conotoxins: Cy5-RgIA, a potent α9α10 nicotinic acetylcholine receptor imaging probe |
| Q26774830 | Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation |
| Q27011502 | Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introduction |
| Q52299798 | Overexpression of the CHRNA5/A3/B4 genomic cluster in mice increases the sensitivity to nicotine and modifies its reinforcing effects. |
| Q51742249 | PET Brain imaging of α7-nAChR with [18F]ASEM: Reproducibility, occupancy, receptor density, and changes in schizophrenia. |
| Q26800058 | PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis |
| Q34291685 | PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. |
| Q38584762 | PET tracers for imaging brain α7 nicotinic receptors: an update |
| Q21090748 | PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings |
| Q39197386 | Peripheral alpha4beta2 nicotinic acetylcholine receptor signalling attenuates tactile allodynia and thermal hyperalgesia after nerve injury in mice |
| Q37395740 | Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes |
| Q42556494 | Photoaffinity labeling the agonist binding domain of alpha4beta4 and alpha4beta2 neuronal nicotinic acetylcholine receptors with [(125)I]epibatidine and 5[(125)I]A-85380. |
| Q47240597 | Photochromism into nanosystems: towards lighting up the future nanoworld |
| Q96131645 | Polyamine regulation of ion channel assembly and implications for nicotinic acetylcholine receptor pharmacology |
| Q36039402 | Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. |
| Q38731444 | Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis |
| Q36949979 | Potential therapeutic uses of mecamylamine and its stereoisomers |
| Q38246678 | Pozanicline for the treatment of attention-deficit/hyperactivity disorder |
| Q41466914 | Pre-Cancerous Lesions in the Oral and Maxillofacial Region: A Literature Review with Special Focus on Etiopathogenesis |
| Q56853416 | Preclinical Characterization of A-582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties |
| Q34778803 | Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties |
| Q48267710 | Prenatal restraint stress decreases the expression of alpha-7 nicotinic receptor in the brain of adult rat offspring |
| Q37014100 | Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission |
| Q26778701 | Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer |
| Q48159280 | Quantification of cerebral nicotinic acetylcholine receptors by PET using 2-[18F]fluoro-A-85380 and the multiinjection approach |
| Q42922769 | Quercetin Enhances Human α7 Nicotinic Acetylcholine Receptor-Mediated Ion Current through Interactions with Ca2+ Binding Sites |
| Q34706080 | Quercetin Inhibits α3β4 Nicotinic Acetylcholine Receptor-Mediated Ion Currents Expressed in Xenopus Oocytes |
| Q39374826 | RVG peptide as transfection reagent for specific cdk4 gene silencing in vitro and in vivo |
| Q42721778 | Radioligand binding characterization of neuronal nicotinic acetylcholine receptors |
| Q90352893 | Raising the Bar On-Bead: Efficient On-Resin Synthesis of α-Conotoxin LvIA |
| Q47829534 | Rat thalamic α₄β₂ neuronal nicotinic acetylcholine receptor occupancy assay using LC-MS/MS. |
| Q36581617 | Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism |
| Q41925230 | Recombinant Newcastle disease virus rL-RVG enhances the apoptosis and inhibits the migration of A549 lung adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine receptors in vitro |
| Q27932881 | Regulation of nicotinic receptor trafficking by the transmembrane Golgi protein UNC-50. |
| Q28506849 | Requirement of nicotinic acetylcholine receptor subunit beta2 in the maintenance of spiral ganglion neurons during aging |
| Q38101354 | Reversible photocontrol of biological systems by the incorporation of molecular photoswitches |
| Q39012626 | Ric-3 chaperone-mediated stable cell-surface expression of the neuronal alpha7 nicotinic acetylcholine receptor in mammalian cells. |
| Q28068951 | Role of Nitric Oxide on Dopamine Release and Morphine-Dependency |
| Q43488024 | Role of mouse cerebellar nicotinic acetylcholine receptor (nAChR) α4β2- and α7 subtypes in the behavioral cross-tolerance between nicotine and ethanol-induced ataxia |
| Q34485695 | Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. |
| Q37025119 | Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine |
| Q43252995 | Selectivity of Imidacloprid for fruit fly versus rat nicotinic acetylcholine receptors by molecular modeling |
| Q30475351 | Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers |
| Q37432219 | Sex-dependent effects of nicotine on the developing brain |
| Q38407564 | Shared long-range regulatory elements coordinate expression of a gene cluster encoding nicotinic receptor heteromeric subtypes |
| Q50268829 | Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers |
| Q35630902 | Smoking cessation and chronic pain: patient and pain medicine physician attitudes |
| Q35839355 | Smoking cessation in pain patients |
| Q28573052 | Spatial and intracellular relationships between the alpha7 nicotinic acetylcholine receptor and the vesicular acetylcholine transporter in the prefrontal cortex of rat and mouse |
| Q36994843 | Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey |
| Q37782324 | State of the Art on Insect Nicotinic Acetylcholine Receptor Function in Learning and Memory |
| Q92989648 | Structural and Functional Analyses of Cone Snail Toxins |
| Q34782188 | Structural answers and persistent questions about how nicotinic receptors work |
| Q38345683 | Structure of neuronal nicotinic receptors |
| Q27657768 | Structure, expression, and function of kynurenine aminotransferases in human and rodent brains |
| Q27681882 | Structure-Function Elucidation of a New -Conotoxin, Lo1a, from Conus longurionis |
| Q35538651 | Suitability of Nicotinic Acetylcholine Receptor α7 and Muscarinic Acetylcholine Receptor 3 Antibodies for Immune Detection: Evaluation in Murine Skin. |
| Q58853249 | Synthesis and Pharmacological Evaluation of α4β2Nicotinic Ligands with a 3-Fluoropyrrolidine Nucleus |
| Q39490266 | Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors |
| Q36825487 | Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity |
| Q58853571 | Synthesis of Epibatidine-Related Δ2-Isoxazoline Derivatives and Evaluation of Their Binding Affinity at Neuronal Nicotinic Acetylcholine Receptors |
| Q55515264 | Synthesis, Structure and Biological Activity of CIA and CIB, Two α-Conotoxins from the Predation-Evoked Venom of Conus catus. |
| Q48169419 | Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles |
| Q39787307 | Targeting cholinesterase inhibitor poisoning with a novel blocker against both nicotinic and muscarinic receptors |
| Q92565525 | Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development |
| Q42489310 | The Cholinergic Signaling Responsible for the Expression of a Memory-Related Protein in Primary Rat Cortical Neurons |
| Q89664052 | The Effects of Nicotine on Development |
| Q92535622 | The Pharmacology of Visual Hallucinations in Synucleinopathies |
| Q38592265 | The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease |
| Q34597013 | The cholinergic antagonist alpha-bungarotoxin also binds and blocks a subset of GABA receptors |
| Q37812418 | The cholinergic system and spatial learning |
| Q40165862 | The effect of maternal smoking and drinking during pregnancy upon (3)H-nicotine receptor brainstem binding in infants dying of the sudden infant death syndrome: initial observations in a high risk population |
| Q45991896 | The effect of nicotine on visuospatial attention in chronic spatial neglect depends upon lesion location. |
| Q35627758 | The effects of prenatal stress on alpha4 beta2 and alpha7 hippocampal nicotinic acetylcholine receptor levels in adult offspring |
| Q39441091 | The expression and pharmacological characterization of nicotinic acetylcholine receptor subunits in HBE16 airway epithelial cells. |
| Q37924850 | The in vivo neurochemistry of the brain during general anesthesia |
| Q34536952 | The neurobiological and behavioral overlaps of nicotine and food addiction |
| Q34126960 | The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer |
| Q42617432 | The nicotinic acetylcholine receptor subunit Mdalpha6 from Musca domestica is diversified via post-transcriptional modification |
| Q34125225 | The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization. |
| Q38942826 | The potential use of rabies virus glycoprotein-derived peptides to facilitate drug delivery into the central nervous system: a mini review |
| Q47884736 | The role of alpha7 nicotinic acetylcholine receptors in inflammatory bowel disease: involvement of different cellular pathways |
| Q33584802 | The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis |
| Q38560778 | The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia |
| Q36214006 | The vagus nerve and the nicotinic anti-inflammatory pathway |
| Q42472318 | The α2-subunit of the nicotinic cholinergic receptor is specifically expressed in medial subpallium-derived cells of mammalian amygdala |
| Q35221001 | The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells |
| Q46359892 | Tobacco nitrosamine N-nitrosonornicotine as inhibitor of neuronal nicotinic acetylcholine receptors |
| Q36359759 | Tonic nicotinic transmission enhances spinal GABAergic presynaptic release and the frequency of spontaneous network activity |
| Q46759626 | Transport of multiple nicotinic acetylcholine receptors in the rat optic nerve: high densities of receptors containing alpha6 and beta3 subunits |
| Q34638044 | Transvascular delivery of small interfering RNA to the central nervous system. |
| Q85059746 | Traumatic Brain Injury Elicits Similar Alterations in α7 Nicotinic Receptor Density in Two Different Experimental Models |
| Q34800479 | Two neuronal nicotinic acetylcholine receptors, alpha4beta4 and alpha7, show differential agonist binding modes. |
| Q40386985 | Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors |
| Q38837028 | Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery |
| Q34304838 | Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases |
| Q34022307 | Water-soluble coenzyme Q10 formulation (Q-TER(®)) in the treatment of presbycusis |
| Q46825391 | Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. |
| Q42751310 | Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - role of gene-gene interaction, personality, and environmental factors |
| Q48262668 | [18 F]Nifene test-retest reproducibility in first-in-human imaging of α4β2* nicotinic acetylcholine receptors |
| Q46811920 | beta2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorder |
| Q39605557 | α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors |
| Q39287268 | α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition. |
| Q28548435 | α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties |
| Q35929504 | α7-Containing and non-α7-containing nicotinic receptors respond differently to spillover of acetylcholine |
| Q35925186 | αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors |
Search more.